Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) Sharpe Ratio

Sharpe ratio is not yet available for PBPH. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar ETFs

The table compares Portfolio Building Block World Pharma and Biotech Index ETF's Sharpe Ratio with other ETFs in the Health & Biotech Equities, Global Equities category across multiple time periods, showing how PBPH's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 12, 2026.

Symbol	Name	1Y Sharpe Ratio
BBC	Virtus LifeSci Biotech Clinical Trials ETF	4.23
SBIO	ALPS Medical Breakthroughs ETF	3.48
XBI	SPDR S&P Biotech ETF	3.05
LFSC	F/m Emerald Life Sciences Innovation ETF	3.05
WLDR	Affinity World Leaders Equity ETF	2.96
IHE	iShares U.S. Pharmaceuticals ETF	2.84
XPH	SPDR S&P Pharmaceuticals ETF	2.78
IBRN	iShares Neuroscience and Healthcare ETF	2.76
CANC	Tema Oncology ETF	2.61
FYLD	Cambria Foreign Shareholder Yield ETF	2.60
PBPH	Portfolio Building Block World Pharma and Biotech Index ETF	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows PBPH's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when PBPH consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does PBPH fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio